WARSAW,
Ind., Dec. 14, 2023 /PRNewswire/ -- Zimmer
Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical
technology leader, today announced that its Board of Directors has
approved the payment of a quarterly cash dividend to stockholders
for the fourth quarter of 2023. The cash dividend of $0.24 per share is payable on or about
January 31, 2024 to stockholders of
record as of the close of business on December 27, 2023.
About the Company
Zimmer Biomet is a global medical technology leader with a
comprehensive portfolio designed to maximize mobility and improve
health. We seamlessly transform the patient experience through our
innovative products and suite of integrated digital and robotic
technologies that leverage data, data analytics and artificial
intelligence.
With 90+ years of trusted leadership and proven expertise,
Zimmer Biomet is positioned to deliver the highest quality
solutions to patients and providers. Our legacy continues to come
to life today through our progressive culture of evolution and
innovation.
For more information about our product portfolio, our operations
in 25+ countries and sales in 100+ countries or about joining our
team, visit www.zimmerbiomet.com or follow on LinkedIn at
www.linkedin.com/company/zimmerbiomet or X / Twitter at
www.twitter.com/zimmerbiomet.
Media
|
Investors
|
Heather
Zoumas-Lubeski
|
Zach Weiner
|
(445)
248-0577
|
(908)
591-6955
|
heather.zoumaslubeski@zimmerbiomet.com
|
zach.weiner@zimmerbiomet.com
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/zimmer-biomet-announces-quarterly-dividend-for-fourth-quarter-of-2023-302014739.html
SOURCE Zimmer Biomet Holdings, Inc.